THE FOLLOW UP
STATEMENT

Bristol Myers Squibb will contribute 6.5 tons of apixaban.

True

Evidence from credible sources supports the statement as accurate. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote
funding

Contribution delivered as described.

Source summary
President Donald J. Trump announced nine agreements with major pharmaceutical companies to align U.S. drug prices with the lowest prices paid in other developed nations (MFN pricing). The deals provide State Medicaid programs access to MFN prices, require companies to offer steep discounts through the administrations TrumpRx channel, and include commitments to repatriate foreign revenue and invest at least $150 billion in U.S. manufacturing. Companies will also donate active pharmaceutical ingredients to a Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The announcement follows prior executive actions and an international agreement with the U.K. to raise net prices there.
View original article →
Latest fact check

The White House announced that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in Eliquis, to the U.S. Strategic Active Pharmaceutical Ingredients Reserve. (whitehouse.gov) Additionally, Bristol Myers Squibb confirmed this donation in their press release. (news.bms.com) Therefore, the statement is accurate.

Sources

Timeline

  1. Update · Dec 21, 2025, 09:00 AMTrue
    The White House announced that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in Eliquis, to the U.S. Strategic Active Pharmaceutical Ingredients Reserve. (whitehouse.gov) Additionally, Bristol Myers Squibb confirmed this donation in their press release. (news.bms.com) Therefore, the statement is accurate.
  2. Update · Dec 21, 2025, 07:49 AMTrue
    Bristol Myers Squibb (BMS) has announced an agreement with the U.S. government to donate more than seven tons of apixaban active pharmaceutical ingredient (API) to the U.S. Strategic Active Ingredient Reserve, aiming to enhance the resilience of the American supply chain. (news.bms.com) This donation is part of a broader initiative to improve the affordability and accessibility of critical medicines for Americans.
  3. Update · Dec 21, 2025, 07:04 AMTrue
    The White House announced on December 19, 2025, that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in Eliquis, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This donation aims to bolster the U.S. supply chain and ensure an adequate supply of critical medications. The statement is accurate as per the official announcement.
  4. Update · Dec 21, 2025, 05:55 AMTrue
    Bristol Myers Squibb (BMS) announced an agreement with the U.S. government to provide Eliquis (apixaban) free to Medicaid starting January 1, 2026, and to donate over seven tons of Eliquis active pharmaceutical ingredient (API) to the U.S. Strategic Active Ingredient Reserve. (news.bms.com) The White House fact sheet also mentions that BMS will contribute tablets representing 6.5 tons of apixaban. The slight discrepancy between 'over seven tons' and '6.5 tons' may be due to rounding or reporting differences, but both sources confirm a substantial contribution of apixaban by BMS.
  5. Update · Dec 21, 2025, 05:08 AMTrue
    The White House announced on December 19, 2025, that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in the drug Eliquis, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This donation aims to bolster the U.S. supply chain and ensure an adequate reserve of critical medications. The announcement was made by President Donald J. Trump as part of a broader initiative to lower prescription drug prices and enhance national health security. (apnews.com)
  6. Update · Dec 21, 2025, 04:25 AMTrue
    The White House announced on December 19, 2025, that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in the blood thinner Eliquis, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). This initiative aims to bolster national health security by reducing reliance on foreign nations and ensuring the United States has an adequate supply of essential medications in the event of an emergency. (whitehouse.gov)
  7. Update · Dec 21, 2025, 02:56 AMTrue
    Bristol Myers Squibb (BMS) announced an agreement with the U.S. government to provide Eliquis (apixaban) for free to the Medicaid program starting January 1, 2026. Additionally, BMS will donate more than seven tons of Eliquis active pharmaceutical ingredient (API) to the U.S. Strategic Active Ingredient Reserve at no cost to the government or taxpayers. (news.bms.com) The White House fact sheet also mentions that BMS will contribute tablets representing 6.5 tons of apixaban, aligning with the company's commitment to improving affordability and access to critical medicines for Americans.
  8. Update · Dec 20, 2025, 11:49 PMTrue
    Bristol Myers Squibb (BMS) has announced an agreement with the U.S. government to provide Eliquis (apixaban) at no cost to the Medicaid program starting January 1, 2026. Additionally, BMS will donate more than seven tons of Eliquis active pharmaceutical ingredient (API) to the U.S. Strategic Active Ingredient Reserve to ensure supply chain resilience. (news.bms.com) The White House fact sheet also mentions that BMS will contribute tablets representing 6.5 tons of apixaban, aligning with the company's commitment to improving affordability and access to critical medicines for Americans.
  9. Update · Dec 20, 2025, 08:47 AMin_progress
    The White House announced on December 19, 2025, that Bristol Myers Squibb will contribute tablets representing 6.5 tons of apixaban, the active ingredient in the drug Eliquis, to the U.S. Strategic Active Ingredient Reserve. Additionally, Bristol Myers Squibb has agreed to provide Eliquis free to the Medicaid program starting January 1, 2026. (news.bms.com) However, the specific details regarding the quantity of apixaban tablets in these agreements are not provided in the available sources. Therefore, while the company's commitment to contribute apixaban is confirmed, the exact quantity of 6.5 tons cannot be independently verified based on the current information.
  10. Original article · Dec 19, 2025
    View article
Back to Countdowns

Comments

Only logged-in users can comment.
Loading…